Clinical Nutrition Market

Most Exhaustive Report

Clinical Nutrition Market - Global Outlook and Forecast 2020-2025

Clinical Nutrition Market

Most Exhaustive Report

Clinical Nutrition Market - Global Outlook and Forecast 2020-2025

SKU : ARZ200609 Published on : July 2020 Pages : 306


Get 10% Free Customization
On This Report.
Customize this report Enquire before buying
data center market research

Get actionable insights on how COVID-19 is impacting your business sector.

Enquire now


Clinical Nutrition Market Size, Share, & Trends Analysis Report By Route Of Administration (Oral Or Enteral and Parenteral), Age Group (Adult and Pediatric), Application (Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Cancer, and Others), End-Users (Hospital, LTC, Homecare, and Individual), Distribution (Institutional Sales, Supermarkets & Hypermarkets, Pharmacy, Specialty Stores, Online Channels, and Others), and Geography (North America, APAC, Europe, Latin America, and the Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025



The global clinical nutrition market reached $51 billion in 2019 is expected to grow at a CAGR of 8% during the forecast period. The growing geriatric population, the increasing incidence of malnutrition, and the increasing prevalence of communicable and non-communicable chronic diseases across the globe are a few major factors driving the growth of the market. Malnutrition is a widespread healthcare challenge, affecting the lives of millions of people around the world. A high incidence of malnutrition among hospitalized patients, especially in APAC, is driving the demand for clinical nutrition, which is considered as the most effective solution for patients to reduce the mortality rate.

The outbreak of novel coronavirus has been a global catastrophe. The symptoms of COVID-19 span a spectrum, ranging from mild, self-limiting flu to pneumonia, acute respiratory distress syndrome, and finally, death. A higher percentage of people have died in Europe than in Asia. A recent meta-analysis from China involving 46,248 patients showed that the most prevalent comorbidities in people infected by COVID-19 were hypertension, followed by diabetes, cardiovascular, and respiratory diseases.


  • The APAC region is expected to generate the largest growth in demand, generating approx. $15 billion in additional revenue by 2025.
  • The parenteral segment is expected to achieve incremental revenue of over $10 billion during the forecast period. 
  • The online sales segment is expected to witness the fastest growth during the forecast period, growing at a CAGR of 11%.
  • The metabolic disorder segment is likely to observe incremental revenue of over $4.5 billion by 2025. 









Revenue: $51 Billion

Compound Annual Growth Rate (CAGR): Over 8%


North America, Europe, APAC, Latin America, and Middle East & Africa


US, Canada, UK, Germany, France, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Saudi Arabia, UAE



This research report includes a detailed segmentation by route of administration, age group, application, end-users, distribution, and geography.



The oral and enteral segment dominates a majority share of the market. The growing health awareness among consumers remains one of the key factors driving the growth of the market. This trend is expected to continue during the forecast period. Although clinical nutritional supplements are generally prescribed to individuals that are at high risk of malnutrition, oral supplements are witnessing widespread inclusions in dieticians’ recommendations.

The growing demand for multichambered premixed parenteral nutritional supplements is a major factor contributing to the growth of the parenteral segment. The parenteral nutritional products are more popular in Chinese and Indian market. The parenteral segment is expected to grow at a CAGR of over 9% during the forecast period.  


The increasing number of preterm births and the high prevalence of malnutrition among children are primarily driving baby clinical nutrition market growth. Although the number of childbirths is declining globally, the growing awareness of the importance of pediatric nutrition is expected to increase the demand during the forecast period.

The growing health awareness in the general population and the increasing prevalence of chronic diseases are primarily boosting the growth of the adult segment. The geriatric population accounts for a majority share of the adult clinical nutrition segment. The high prevalence of diseases such as cancer, chronic liver disease, COPD, and diabetes is projected to drive the demand for several oral supplement products that support patients.


The large prevalence of malnutrition among hospitalized patients is particularly driving the market. This segment contributed about 39% of the clinical nutrition market revenue in 2019. Clinical nutrition is considered the most efficient way to treat malnutrition. The APAC region accounts for the largest market for malnutrition clinical nutrition supplements. The region is expected to grow at the fastest CAGR during the forecast period. China, India, Japan, Australia, and South Korea are some of the key markets for nutritional health supplement products in the region.

Metabolic disorders contribute the second largest application segment for the clinical nutrition market. In recent years, it has become highly prevalent across the world, particularly in the US. About 34% of adult Americans are estimated to have metabolic disorders. Thus, clinical nutrition is highly recommended for patients suffering from this syndrome.


Hospitals constitute the largest end-user for clinical nutrition products globally. The rising incidence of chronic diseases, along with the growing number of preterm births and surgeries, has led to the growth of demand for clinical nutrition in hospitals.

Long-term care facilities (LTC) include includes ambulatory care facilities. The prevalence of protein-energy malnutrition in nursing homes residents range from 25–85%. Malnourishment in the elderly population can lead to poor clinical outcomes and increase the risk of mortality. Thus, clinical nutrition is generally recommended for patients in LTC facilities, which is driving growth.

Clinical nutrition also plays a significant role in home-based healthcare services. The demand for home care services is likely to boost the market for clinical nutrition during the forecast period. The home care segment is expected to witness an absolute growth of 59% during the forecast period. 


Supermarkets and hypermarkets have been dominating the distribution landscape, and the channel is expected to continue its momentum during the forecast period. Drug stores and pharmacies are the most preferred outlets after supermarkets & hypermarkets. Countries such as India, China, and Japan are oriented toward supermarkets and traditional retail outlets. The other significant countries, such as Australia, depend keenly on drug stores and pharmacies.

The online channel has gained momentum post the rapid internet penetration and advancement in e-commerce shopping sites. The global clinical nutrition market by online channel is expected to reach revenues of $13 billion by 2025. The onset of the COVID-19 pandemic has surged the demand for nutritional products and supplements. However, the distribution system has highly been affected due to lockdown and closure of national borders.


APAC accounts for the largest market share of the global clinical nutrition market. It is expected to witness the fastest growth during the forecast period. The large prevalence of metabolic disorders such as diabetes is boosting the demand for nutritional supplement products. China has the largest number of people who have diabetes globally, with around 116 million people in 2019. The proportion of cancer deaths in Asia is about 57.3% higher than the cancer incidence rate. Thus, with such a prevalence of chronic diseases, the demand for clinical nutrition products is expected to grow. The rise in the ageing population in the country is driving the medical nutrition market India.

North America was the second-largest clinical nutrition market accounting for 28% of the revenues in 2019. The US region is the major revenue contributor to the North America market. Due to the impact of COVID-19, the sales of medical nutrition products increased significantly in certain regions like China and the US.


The global clinical nutrition market share is fragmented and is highly competitive, with the presence of a large number of significant vendors in the market. The increasing demand for clinically proven formulas and scientific research is the major differentiating factor in the market than can substantially increase the level of investment required. As medical practitioners and pharmacists can serve as influencers for clinical nutrition products, vendors must establish a profitable relationship with them. Constant online engagement is necessary to increase influence among millennial and internet-oriented consumers as they consider online forums as a tool of suggestion and clarity. Collaborations with third-party vendors are crucial for market penetration.

The global clinical nutrition market research report includes industry analysis with revenue and forecast insights for the following segments: 

Market by Route of Administration   

  • Oral or Enteral
  • Parenteral 

By Type     

  • Pediatric
  • Adult 

By Application  

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Cancer
  • Others

By End-user     

  • Hospital
  • LTC
  • Homecare
  • Individual 

By Distribution 

  • Institutional Sales
  • Supermarkets & Hypermarkets
  • Pharmacy
  • Specialty Stores
  • Online Channels
  • Others 

By Geography 

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • UAE


  1. What is the market size and compound annual growth rate of the clinical nutrition market?
  2. What are the emerging clinical nutrition market trends that is going to drive the industry during the forecast period?
  3. What are the factors influencing the growth of the hospitals segment during the forecast period?
  4. What is the growth of the adult and pediatric segment market shares by 2025?
  5. Who are the major key players in the clinical nutrition market, and what are their market shares?
  6. How is the growing population in the Asia Pacific region impacting the growth of the clinical nutrition market?
  7. What is the impact of the COVID-19 pandemic on the global medical nutrition market size? 


Client Speak

data center market size

Erik Young

CEO, Co-founder
Audink Inc., DBA Audios

The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow.

data center market

Benjamin Arnold

Senior Product Manager

I recently purchased a key Arizton Industry Outlook & Forecast in order to better understand growth for specific market segments and the macro environmental factors impacting this growth. I found Ariztonā€™s coverage of the market dynamics and key takeaways to be insightful and valuable. The segmentation breakouts gave me the information I needed to guide strategic considerations.

data center market research

Hallmann, Nickolai

Manager Market Analyst Power
Generation & Energy
Rolls-Royce Power Systems AG

The provided information by Arizton really met my expectations. Especially the deep information about the datacenter ecosystem was very helpful. Furthermore, I absolutely appreciate the optimal service from the key account managers of Arizton. It was always a pleasure working with them.

Customer Service



Copyright 2019 - Arizton

data center market